Shopping Cart
Remove All
Your shopping cart is currently empty
LW-216 is a TrxR1 inhibitor that induces cell apoptosis (Apoptosis) and possesses antitumor activity.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,520 | 6-8 weeks | 6-8 weeks | |
| 50 mg | $1,980 | 6-8 weeks | 6-8 weeks | |
| 100 mg | $2,500 | 6-8 weeks | 6-8 weeks |
| Description | LW-216 is a TrxR1 inhibitor that induces cell apoptosis (Apoptosis) and possesses antitumor activity. |
| In vitro | LW-216 (5-25 μM, 24 h) selectively decreases the TrxR1 protein levels in NCI-H460 and A549 cells, subsequently inducing apoptosis. |
| In vivo | LW-216 administered intravenously (8 mg/kg, once every two days for 18 days) effectively suppressed tumor growth in a xenograft mouse model employing NCI-H460 cells. This treatment regimen significantly reduced bioluminescence intensity and increased the levels of apoptosis-inducing proteins Bax and Cleaved Caspase-3. Concurrently, there was a noticeable reduction in the expression of the proliferation marker Ki67. |
| Molecular Weight | 485.57 |
| Formula | C30H31NO5 |
| Cas No. | 2146090-18-6 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.